Drawing for HIPRA

USPTO serial 79308341

HIPRA

Reviewed by CopyMark Law Group

Reg. 6749226Status 700Registered
Filing date
Status date
Registration date
Jun 7, 2022
Examiner
FALK, JONATHAN ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HIPRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leigh Ann Lindquist

Leigh Ann Lindquist Sughrue Mion PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, biological vaccines for human and veterinary use; biological preparations for medical and veterinary use namely veterinary vaccines; veterinary preparations for the treatment of intestinal bacteria, anti-infective products for veterinary use; insecticidal washing products for veterinary use; veterinary products and substances, namely, vaccines for prevention of animal illness; biological reagents for veterinary use; diagnostic reagents for veterinary use; reagents for clinical analyses for veterinary purposes; reagents for microbiological analyses for veterinary purposes; reagents for chemical analyses for veterinary purposes; reagents for veterinary diagnosis; reagents for diagnostic tests for veterinary purposes; reagents for use with analyzers for veterinary purposes; reagents for use in analyses for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; reagents for use in analysis for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for veterinary use; reagents and media for medical and veterinary diagnostic purposes; nucleic acid sequences for medical and veterinary use; dietary supplements for veterinary use; veterinary substances and preparations namely, vaccines for prevention of animal illness; oral vaccine preparations; vaccine preparations for human use; vaccines; influenza vaccines; vaccines against pneumococcal infections; vaccines for horses; vaccines for cattle; vaccines for infections in animal hooves; vaccines for human use; veterinary vaccines; viral vaccinesACTIVE—
009Apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; computers and computer peripherals; downloadable and recorded computer software to trace application of veterinary products; spectrocolorimeters, other than those used for medical diagnostics; downloadable and recorded remote diagnostic software to trace the application of veterinary products; ultrasonic diagnostic apparatus for laboratory use; electronic apparatus for checking the sterility of pharmaceutical and veterinary products and injectable solutions; downloadable and recorded artificial intelligence software for veterinary health diagnosis; downloadable and recorded artificial intelligence software for analysis purposes for veterinary health diagnosisACTIVE—
010Veterinary apparatus and instruments for administration of veterinary vaccines, namely, jet injectors; artificial limbs, eyes and teeth; suture materials; automatic vaccination apparatus; dialysis apparatus for veterinary use; X-ray apparatus for veterinary use; collimation position indicator apparatus for veterinary use; bolus applicators for veterinary use; trays for holding veterinary instruments; blood collection bags for veterinary use; blood collection bags for veterinary use, empty; elastrator for veterinary purposes; electrocardiographs for veterinary use; X-ray sheets for veterinary use; caps for protecting the hair to be worn by veterinary professionals; latex gloves for veterinary use; protective gloves for veterinary use; disposable gloves for veterinary use; gloves for veterinary use; tools for veterinary diagnosis, namely, diagnostic apparatus for the detection of virus, and diagnostic kits comprised of diagnostic apparatus for the detection of virus; castration instruments for veterinary use; ultrasonic diagnostic instruments for veterinary use; ultrasonic cleaning instruments for veterinary use; X-ray frames for veterinary use; protective mouth masks for veterinary use; protective nose masks for veterinary use; balling guns for veterinary use, refractometers for veterinary purposes; x-ray supports for veterinary use; nerve connecting mesh tubes for veterinary use; sample tubes for veterinary use; support bandages for veterinary use; protective visors for veterinary use; automatic medical apparatus for administering doses of drugs by injection to animals; medical and surgical knives for cutting the tissue and organs of human beings or animals; veterinary obstetrics tools for the birth of live animals; medical and surgical cutting instruments for cutting the tissue and organs of human beings or animals; wheels for pets being mobility aids; radiation protection textiles for use in the therapeutic treatment of animals, injection needles for medical use; hypodermic needles for injection; automatic medical apparatus for administering doses of drugs by injection to animals; automatic medical apparatus for administering doses of drugs by injection to humans; injection device for pharmaceutical products; hypodermic injection devices; injection instruments without needles; hypodermic syringes for injections for medical purposes; syringes for injections; injection sleeves for medical use; blood removal needles; blood testing apparatus; automated blood collection apparatus; automated apparatus for separating blood; blood testing apparatus for medical use; blood glucose monitoring apparatus; autologous blood processing apparatus; blood glucose testing apparatus; medical apparatus for measuring oxygen content in the blood; medical apparatus for testing blood glucose level; apparatus for the recovery of autologous blood; apparatus for cleaning blood during surgical procedures; apparatus for blood tests for medical use; blood collection bags for medical purposes, empty; blood collection bags for medical use; blood collection bags for veterinary use; blood warmers; blood filters; filters for blood and blood components; automated instruments for blood separation; automated instruments for collecting blood; blood testing instruments; autologous blood processing instruments; electrical instruments for medical use in blood diagnostics; blood glucose meter; roller mixers for blood samples; electronic blood oxygen saturation monitors for medical use; blood testing apparatus; capillary tubes for blood; blood collection tubes for medical use; blood collection tubes for surgical use; tubes for collecting blood; blood centrifuging tubules for medical use; ventilators for medical use; medical masksACTIVE—
035Retail and wholesale store services and via global computer networks featuring pharmaceutical, veterinary, sanitary products and material, surgical medical and veterinary apparatus, devices and instruments, as well as of computer software related to the biomedical and pharmaceutical sector; advertising services related to pharmaceutical, veterinary, sanitary products and material, surgical, medical and veterinary apparatus, devices and instruments; as well as computer software related to the biomedical and pharmaceutical sectorACTIVE—
042Scientific and technological services, as well as associated research and design services, namely, scientific research, analysis and testing in the field of pharmaceutical, veterinary, sanitary products and material, surgical medical and veterinary apparatus, devices and instruments, as well as of computer software related to the biomedical and pharmaceutical sector; industrial analysis and research services in the field of pharmaceutical, veterinary, sanitary products and material, surgical medical and veterinary apparatus, devices and instruments, as well as of computer software related to the biomedical and pharmaceutical sector and industrial design services; quality control services and authentication services in the field of pharmaceutical, veterinary, sanitary products and material, surgical medical and veterinary apparatus, devices and instruments, as well as of computer software related to the biomedical and pharmaceutical sector; design and development of computer equipment and software; research and development services relating to vaccines; veterinary laboratory services; services for assessing the effectiveness of veterinary medicines; design of laboratory animal housing systems; biotechnology research for determining the neuronal survival of molecules in animal models; research regarding farm animal breeding; genetic tests of laboratory animals for research; consultancy in pharmaceutical research; consultancy related to pharmacology; consultancy related to pharmacogenetics research; consultancy related to pharmaceutical research and development; development of pharmaceutical preparations and medicines; development of pharmaceutical products; clinical studies for pharmaceutical products; evaluation of pharmaceutical products; scientific and medical information regarding pharmaceutical products and clinical trials; inspection of pharmaceutical products; scientific research in the field of pharmacy; research in the field of pharmacogenetics; research regarding pharmaceutical products; research and development in the field of pharmacy and biotechnology; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; conducting early evaluations in relation to new pharmaceutical products; drug development services; drug discovery services; pharmaceutical product efficacy assessment services; medical and pharmacological research services; pharmaceutical research and development services; information technology services for the pharmaceutical and health-care industries, namely, information technology consulting services; provision of information regarding results of clinical trials relating to pharmaceutical products; electronic storage of medical records; design and development of medical diagnostic apparatus; scientific research for medical purposes; medical laboratories; programming for computers in the medical field; information and data services regarding medical and veterinary research and development, services of a medical laboratory; non-medical ultrasound imaging services; provision of scientific information regarding medical disorders and their treatment, development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; services for assessing the effectiveness of veterinary medicines; biological research and analysis; creation and development of computer software in the pharmaceutical, medical, veterinary, sanitary and diagnostic field; clinical research; conducting clinical trials; blood testing services for scientific research; analytical services relating to the assessment of bacteria content in liquidsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 20, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 19, 2022FIMPFINAL DISPOSITION PROCESSED—
Sep 7, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 7, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 7, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 29, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 1, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Feb 15, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 15, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jan 26, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 26, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 26, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jan 5, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 5, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 5, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 30, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 19, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 19, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 19, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 19, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 19, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 20, 2021RFNTREFUSAL PROCESSED BY IB—
Jun 1, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 1, 2021RFRRREFUSAL PROCESSED BY MPU—
May 29, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 28, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2021DOCKASSIGNED TO EXAMINER—
Apr 20, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 14, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 8, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance